Thore Lorenzen

620 total citations
15 papers, 367 citations indexed

About

Thore Lorenzen is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Thore Lorenzen has authored 15 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Thore Lorenzen's work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (4 papers) and Viral-associated cancers and disorders (4 papers). Thore Lorenzen is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (4 papers) and Viral-associated cancers and disorders (4 papers). Thore Lorenzen collaborates with scholars based in Germany, Switzerland and India. Thore Lorenzen's co-authors include Klaus‐Peter Hunfeld, Andi Krumbholz, Anke Hildebrandt, Michael Baier, H.-J. Fricke, Michael Kiehntopf, Svea Sachse, E. Sträube, Andreas Plettenberg and Albrecht Stoehr and has published in prestigious journals such as Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

Thore Lorenzen

14 papers receiving 355 citations

Peers

Thore Lorenzen

PARAS

ONCOL

EPIDE

EEBS

Alex Espinosa United States

Takahiro Maeki Japan

Kristin Mullins United States

Souichi Yamada Japan

Rene Hull United States

Michelle Dupuis United States

María‐Dolores Tabar Spain

Linda Easterbrook United Kingdom

Lora D. Thomas United States

G. J. P. Schaap Netherlands

Alex Espinosa United States

Thore Lorenzen

176 ×0.8

97 ×0.5

PARAS

33 ×0.4

ONCOL

97 ×1.3

EPIDE

53 ×0.8

EEBS

Citations per year, relative to Thore Lorenzen Thore Lorenzen (= 1×) peers Alex Espinosa

Countries citing papers authored by Thore Lorenzen

Since Specialization

Citations

This map shows the geographic impact of Thore Lorenzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thore Lorenzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thore Lorenzen more than expected).

Fields of papers citing papers by Thore Lorenzen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thore Lorenzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thore Lorenzen. The network helps show where Thore Lorenzen may publish in the future.

Co-authorship network of co-authors of Thore Lorenzen

This figure shows the co-authorship network connecting the top 25 collaborators of Thore Lorenzen. A scholar is included among the top collaborators of Thore Lorenzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thore Lorenzen. Thore Lorenzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Plettenberg, Andreas, N. H. Brockmeyer, Burkhard Haastert, et al.. (2011). Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDS. Infection. 39(1). 3–12. 13 indexed citations

Lorenzen, Thore. (2010). Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients. HIV/AIDS - Research and Palliative Care. 2. 151–151. 2 indexed citations

Lorenzen, Thore, et al.. (2009). Effective Treatment of Patients in a Deep Salvage Situation with "Non-Active HAART": Experiences with the Expert Advice System RADATA. Infection. 37(6). 528–533.

Kremer, Heidemarie, Gabriele Arendt, N. H. Brockmeyer, et al.. (2009). HIV or HIV-Therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV. European journal of medical research. 14(4). 139–46. 15 indexed citations

Hildebrandt, Anke, Klaus‐Peter Hunfeld, Michael Baier, et al.. (2007). First confirmed autochthonous case of human Babesia microti infection in Europe. European Journal of Clinical Microbiology & Infectious Diseases. 26(8). 595–601. 163 indexed citations

Lorenzen, Thore, et al.. (2007). CCR5 antagonists in the treatment of treatment-experienced patients infected with CCR5 tropic HIV-1.. PubMed. 12(9). 419–25. 9 indexed citations

Wyen, Christoph, Christian Hoffmann, Jürgen K. Rockstroh, et al.. (2004). Progressive Multifocal Leukencephalopathy in Patients on Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(2). 1263–1268. 54 indexed citations

Albrecht, D., et al.. (2003). Epidemiology of HHV-8 infection in HIV-positive patients with and without Kaposi sarcoma: diagnostic relevance of serology and PCR. Journal of Clinical Virology. 30(2). 145–149. 18 indexed citations

Albrecht, D., Bernhard Zöllner, Heinz‐Hubert Feucht, et al.. (2002). Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy. Journal of Clinical Virology. 24(1-2). 93–98. 17 indexed citations

10.

Paech, Volker, Thore Lorenzen, W Meigel, et al.. (2002). Remission of CutaneousMycobacterium haemophilumInfection as a Result of Antiretroviral Therapy in a Human Immunodeficiency Virus–Infected Patient. Clinical Infectious Diseases. 34(7). 1017–1019. 10 indexed citations

11.

Plettenberg, Andreas, et al.. (2002). Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.. PubMed. 7(1). 19–24. 3 indexed citations

12.

Paech, Volker, Thore Lorenzen, Andrea Stoehr, et al.. (2002). Remission of a cutaneous Mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection.. PubMed. 7(11). 477–9. 15 indexed citations

13.

Lorenzen, Thore, D. Albrecht, Volker Paech, et al.. (2002). HHV-8 DNA in blood and the development of HIV-associated Kaposi's sarcoma in the era of HAART--a prospective evaluation.. PubMed. 7(6). 283–6. 10 indexed citations

14.

Szeimies, Rolf‐Markus, Thore Lorenzen, Sigrid Karrer, Andreas Plettenberg, & Christoph Abels. (2001). Photochemotherapie kutaner Aids-assoziierter Kaposi-Sarkome mit Indocyaningr�n und Laserlicht. Der Hautarzt. 52(4). 322–326. 4 indexed citations

15.

Plettenberg, Andreas, Thore Lorenzen, H Rasokat, et al.. (2000). Bacillary Angiomatosis in HIV-Infected Patients – An Epidemiological and Clinical Study. Dermatology. 201(4). 326–331. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact